IGEA Pharma N.V.
IGEA announces changes in its board
IGEA Pharma N.V. / Key word(s): Miscellaneous IGEA announces changes in its board Hoofddorp, the Netherlands, 2 June 2020. IGEA Pharma N.V. (SIX: IGPH) today announced the nomination of Mr. Lieven Baten for election as non-executive director of IGEA at the upcoming general meeting on 3 July 2020. Lieven Baten is a partner at Acalis, with which IGEA has previously signed a strategic partnership for the distribution of its products. The CV of Lieven Baten is available at https://www.igeapharma.nl/category/information-for-shareholders/ together with the convening notice, the agenda, the explanatory notes and other documents for the general meeting of 3 July 2020. *** About IGEA IGEA is listed on the SIX Swiss Exchange (ticker IGPH) and is headquartered in Hoofddorp, the Netherlands. Find out more at www.igeapharma.nl Contacts Disclaimer The information contained in this press release has been carefully prepared. However, IGEA bears and assumes no liability of whatever kind for the correctness and completeness of the information provided herein. IGEA does not assume an obligation of whatever kind to update or correct information contained in this press release whether as a result of new information, future events or for other reasons. This publication may contain specific forward-looking statements and assessments or intentions concerning IGEA and its business. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of IGEA and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties, readers should not rely on forward-looking statements. IGEA assumes no responsibility to update forward-looking statements or to adapt them to future events or developments, except as may be required by law. Additional features: File: 20200602 igea nv_press release End of ad hoc announcement |
Language: | English |
Company: | IGEA Pharma N.V. |
Siriusdreef 17 | |
2123 WT Hoofddorp | |
Netherlands | |
Phone: | +31 23 568 9494 |
E-mail: | info@igearesearch.com |
Internet: | www.igeapharma.nl |
ISIN: | NL0012768675 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1061383 |
End of Announcement | EQS Group News Service |